• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Synta Pharmaceuticals Corp

+ Add to Watchlist

SNTA:US

2.8000 USD 0.0600 2.10%

As of 20:10:00 ET on 12/19/2014.

Snapshot for Synta Pharmaceuticals Corp (SNTA)

Open: 2.8400 Day's Range: 2.7200 - 2.8500 Volume: 1,333,843
Previous Close: 2.8600 52wk Range: 2.5400 - 7.2200 1-Yr Rtn: -42.51%

Stock Chart for SNTA

No chart data available.
  • SNTA:US 2.8000
  • 1D
  • 1M
  • 1Y
2.8600
Interactive SNTA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SNTA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.0200
Est. EPS (USD) (12/2014) -0.8860
Est. PEG Ratio -
Market Cap (M USD) 304.91
Shares Outstanding (M) 108.90
30 Day Average Volume 1,027,446
Price/Book (mrq) 3.6416
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SNTA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SNTA

Synta Pharmaceuticals Corp. is a biopharmaceutical company developing small-molecule drugs for inflammatory diseases, cancer, and diabetes. The Company has drug candidates in human clinical trials and additional programs in preclinical studies.

Anne C WhitakerPresident/CEOChen SchorExec VP/COO
Marc R SchneebaumSenior VP/CFOVojo VukovicSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for SNTA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil